StockData
Electra Therapeutics, Inc. logo

Electra Therapeutics, Inc. (ETRA) stock

ETRANasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 12, 2026
$8.35+0.04 (+0.48%)

Close on Nov 17, 2026Market cap $524.94MP/E –Yield –

Electra Therapeutics EPS

Diluted earnings per share is net income divided by the share count including options and convertible securities.

Quarterly eps

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026-$3.47–
Q3 FY2025Sep 30, 2025-$616.86–

More Electra Therapeutics figures

See a number that looks wrong?